(Press-News.org) The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
"The use of adult stem cells, derived from the patient's own bone marrow, presents a potential new type of therapy to benefit individuals after they suffer a heart attack," says the study's principal investigator Jay H. Traverse, MD, cardiologist at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis, Minn. "Also, these types of stem cells do not possess any of the ethical concerns of embryonic stem cell research."
"While the objective of phase 1 clinical trials is to assess safety, researchers also look for hints of efficacy that have been revealed in previous studies," says Traverse. "Based on indications of some improvements in various European studies, we sought to examine whether this therapy could improve ejection fraction at six months, and whether it had an effect on attenuating adverse left ventricular remodeling as measured by cardiac MRI."
In this single-center trial, the researchers enrolled 40 patients with STEMI, randomizing them in a 3:1 ratio to 100 million autologous BMCs versus placebo, administered three to ten days following successful primary angioplasty and stenting of the left anterior descending coronary artery. Importantly, the researchers elected to deliver cells by an intracoronary infusion as opposed to the stop-flow technique that had been used in all preceding trials and all patients received an identical number of cells.
Administration of BMC was safely performed in all patients with minimal major adverse clinical event rates, and all patients remain alive to date, Traverse and colleagues reported.
While the BMC cell therapy was associated with a significant improvement in left ventricular ejection fraction at six months (49% to 55.2%), the study failed to demonstrate that the cell therapy was superior to placebo because of the similar improvement in the small placebo group (48.6% to 57%). However, the BMC group experienced a significant improvement in left-ventricular volumes at six months compared with the placebo group.
"A review of the available clinical literature reveals a split in the benefit of left ventricular ejection fraction—some studies show no benefit and others show a small improvement," Traverse explains. "Any number of factors can influence this outcome: the way the ejection fraction is measured, the timing of BMC administration, how many cells are delivered, the type of STEMI patient population. There are a lot of variables, leading some to question whether ejection fraction is the most appropriate endpoint for cell therapy trials."
"To this point, no study has been properly powered to assess the appropriate timing of BMC administration after a heart attack," says Traverse.
However, Traverse and his colleagues at the Minneapolis Heart Institute® are involved with the TIME trial, sponsored by the National Heart, Lung and Blood Institute's Cardiovascular Cell Therapy Research Network (CCTRN), which is randomizing patients to BMCs at three or seven days post-STEMI to determine the most appropriate timing to administer the stem cells following a heart attack.
###
This study was supported by the Jon H. Dehaan Foundation. Cell processing was supported by the Production Assistance for Cellular Therapies. The infusion catheters were supplied by Boston Scientific, headquartered in Natick, Mass.
Minneapolis Heart Institute®
The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.
Minneapolis Heart Institute Foundation
The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.
EAST LANSING, Mich. — Women tend to believe the scientific consensus on global warming more than men, according to a study by a Michigan State University researcher.
The findings, published in the September issue of the journal Population and Environment, challenge common perceptions that men are more scientifically literate, said sociologist Aaron M. McCright.
"Men still claim they have a better understanding of global warming than women, even though women's beliefs align much more closely with the scientific consensus," said McCright, an associate professor with ...
The research, unveiled at a press conference today (14 September 2010), shows that the watercress compound is able to interfere with the function of a protein which plays a critical role in cancer development.
As tumours develop they rapidly outgrow their existing blood supply so they send out signals which make surrounding normal tissues grow new blood vessels into the tumour which feed them oxygen and nutrients.
The research, led by Professor Graham Packham of the University of Southampton, shows that the plant compound (called phenylethyl isothiocyanate) found ...
(PHILADELPHIA) An abrupt, fatal heart attack in a young athlete on the playing field is a tragedy destined to repeat itself over and over until more is understood about hypertrophic cardiomyopathy (HCM), a genetic disorder that is the most common cause of sudden death in young people but which affects people of all ages. So says a task force of cardiologists and cardiac biologists, headed by Thomas L. Force, M.D., James C. Wilson Professor of Medicine at Thomas Jefferson University, in the September 14th online edition of the journal Circulation.
Their special report ...
Scientists have for the first time estimated the physical footprint of human activities on the deep seafloor of the North East Atlantic. The findings published in the journal PLoS ONE reveal that the area disturbed by bottom trawling commercial fishing fleets exceeds the combined physical footprint of other major human activities considered.
The deep seafloor covers approximately 60% of Earth's surface, but only a tiny fraction of it has been studied to date. Yet as technology advances and resources from relatively shallow marine environments are depleted, human impacts ...
Global fisheries, a vital source of food and revenue throughout the world, contribute between US$225-$240 billion per year to the worldwide economy, according to four new studies released today. Researchers also concluded that healthier fisheries could have prevented malnourishment in nearly 20 million people in poorer countries.
This first comprehensive, peer-reviewed estimate of the global economic contribution of fisheries was published online today in four papers as part of a special issue of the Journal of Bioeconomics.
This research, conducted by the University ...
GOES-13 captured a look at System 92L this morning as it continues moving through the central Caribbean, and it's looking more and more like a tropical depression.
As the Geostationary Operational Environmental Satellite called GOES-13 satellite keeps relaying data to NOAA (who manages the satellite) and the NASA GOES Project at NASA's Goddard Space Flight Center in Greenbelt, Md., the images created by the NASA GOES Project reveal that System 92L appears to be taking on the appearance of a tropical depression. In the imagery captured today, Sept. 14 at 1340 UTC (9:40 ...
ROCKVILLE, Maryland, September 14, 2010 – Neuralstem, Inc. (NYSE Amex: CUR) announced that its spinal cord stem cells survived in rat brains affected by stroke and differentiated predominantly into neurons. The transplanted animals showed significant improvement in some motor skill and strength measurements. The study entitled, "Intracerebral Implantation of Adherent Human Neural Stem Cells To Reverse Motor Deficits in Chronic Stroke Rats," was presented earlier today by senior study author, Dr. Shinn-Zong Lin, M.D., Ph.D., at the Stem Cells USA & Regenerative Medicine ...
An astronomer may have caught a cannibalistic star in the act of devouring a companion and making a second generation of exoplanets from the resulting orbiting disk.
Using data from NASA's Chandra X-ray Observatory, Joel Kastner, professor at Rochester Institute of Technology, has found evidence that a variable star in the constellation of Pisces, BP Piscium, is not the young star it appears to be, but is more likely a one billion-year-old red giant that has gobbled up a star or planet in its vicinity.
The star's extreme properties have puzzled astronomers since Kastner ...
"The IFFS's 'Surveillance 2010' report, compiled by Professor Ian Cooke and published on 14 September 2010, illustrates this for over 100 countries. The survey highlights how widely assisted reproductive technologies (ART) are being used and how different cultures are regulating services in different ways. In most countries there is no state or insurance support, so these services are costly and frequently beyond the reach of many families. In some countries access to donor gametes is denied or supply is limited.
To address the safety of patients that seek treatment abroad, ...
Low Adherence with Regular Fecal Occult Blood Test Screening Among Insured Patients
In a large U.S. health plan, nearly one-half of patients who initiated biennial fecal occult blood test (FOBT) screening did not adhere to subsequent colorectal screening in the ensuing 2-year period, compromising the effectiveness of the screening endeavor which hinges on regular screening. Analyzing data on 11,110 patients enrolled in a Washington State health plan who completed an FOBT during the baseline period (2000-2001), researchers found 47 percent received no colorectal screening ...
